Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / GENOMIC REV ETF
-
Total 13F shares
-
27,310,972
-
Share change
-
+3,596,108
-
Total reported value
-
$699,040,899
-
Put/Call ratio
-
90%
-
Price per share
-
$25.60
-
Number of holders
-
236
-
Value change
-
+$92,400,865
-
Number of buys
-
58
-
Number of sells
-
136
Institutional Holders of ARK ETF TR - GENOMIC REV ETF (ARKG) as of Q3 2024
As of 30 Sep 2024,
ARK ETF TR - GENOMIC REV ETF (ARKG) was held by
236 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,310,972 shares.
The largest 10 holders included
BNP PARIBAS FINANCIAL MARKETS, JPMORGAN CHASE & CO, BANK OF AMERICA CORP /DE/, Main Management ETF Advisors, LLC, GOLDMAN SACHS GROUP INC, CITIGROUP INC, MORGAN STANLEY, UBS Group AG, WELLS FARGO & COMPANY/MN, and LPL Financial LLC.
This page lists
237
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.